|
Supportive breast cancer treatment of patients with Avemarresulted in significant amelioration /ceasing of the side effects of chemotherapy, and increase of body mass.
As a supportive breast cancer treatment it shows the patients resulted in major improvements of several components of quality of life. These effects were manifested after three months of treatment and remained stabilized through the entire period of the study.
The following advantages can be expected from Avemaras a supportive Colon cancer treatment use of in the therapy of advanced colorectal and colon cancer patients: easy (oral) application with no or negligible side effects and, longer overall- and progression-free survivals
Supportive lung cancer treatment of terminal lung cancer patients resulted in considerable improvements of several components of quality of life.
|
|
|
 |
Ref.: CNN World Report | |
|
|
|
 |
Ref.: British Journal of Cancer (2003) 89, 465-469 | | |
